medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Deep Transfer Learning-based COVID-19 prediction using Chest X-rays
Saurabh Kumar, Shweta Mishra, Sunil Kumar Singh*
Department of Computer Science & Information Technology,
Mahatma Gandhi Central University, Bihar, India
*Email: sksingh@mgcub.ac.in; sunilsingh.jnu@gmail.com
*ORCID iD: 0000-0001-8954-6648
Abstract
The novel coronavirus disease (COVID-19) is spreading very rapidly across the globe because of its
highly contagious nature, and is declared as a pandemic by world health organization (WHO).
Scientists are endeavoring to ascertain the drugs for its efficacious treatment. Because, till now, no
full-proof drug is available to cure this deadly disease. Therefore, identifying COVID-19 positive
people and to quarantine them, can be an effective solution to control its spread. Many machine
learning and deep learning techniques are being used quite effectively to classify positive and
negative cases. In this work, a deep transfer learning-based model is proposed to classify the
COVID-19 cases using chest X-rays or CT scan images of infected persons. The proposed model is
based on the ensembling of DenseNet121 and SqueezeNet1.0, which is named as DeQueezeNet. The
model can extract the importance of various influential features from the X-ray images, which are
effectively used to classify the COVID-19 cases. The performance study of the proposed model
depicts its effectiveness in terms of accuracy and precision. A comparative study has also been done
with the recently published works and it is observed the performance of the proposed model is
significantly better.
Keywords COVID-19, Deep Learning, Transfer learning, Machine Learning, DenseNet, SqueezeNet
1.

Introduction

COVID-19 stands for Coronavirus Disease-19, is emerged as an epidemic, which has attracted
worldwide attention since December-2019. Initially, it was referred to as the novel coronavirus 2019
(2019-nCoV) but later on, was renamed as COVID-19 officially by the World Health Organization
(WHO) on February 11, 2020 [1]. Coronavirus disease (COVID-19) is an infectious disease, caused
by a new virus. This disease makes humans suffer from respiratory illness with symptoms like
cough, high fever, and in severe cases, difficulty in breathing.
If we look at the history of coronaviruses, these are the viruses that cause disease in mammals and
birds. In humans, coronaviruses cause respiratory tract infections (RTI) [2] that can vary from mild
to lethiferous. The first virus of the family Coronaviridae was SARS-CoV, which stands for severe
acute respiratory syndrome coronavirus. Its outburst started in Guangdong, China, and spread to
many other countries in Southeast Asia. The last case of SARS-CoV was reported in September 2003
and it infected 8000 persons causing 774 deaths with a case mortality rate of 9.6%[1].
After nine years around in mid-2012, another deadly virus appeared in the Middle East from this
family, which was known as Middle East respiratory syndrome coronavirus (MERS-CoV)[1, 3].
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

When we compare the case mortality rate of MERS-CoV with SARS-CoV, it is quite high and is
around 35%.
COVID-19 is again a novel virus from the Coronaviridae family, which emerged from the City of
Wuhan China [4], has spread to several other countries. It is a zoonotic origin virus i.e. transmitted
from animals to humans; now it is transmitting between humans to humans.
Novel coronavirus or COVID-19 spread like a wildfire, wilder than the SARS in 2003. Figure 1
shows the worldwide infected cases at an interval of 10 days. The vertical axis represents the
numbers of confirmed, recovered, and death cases. As shown in the figure, on the date 02.05.2020
number of confirmed, recovered and death case are 3,427,343, 1,093,112 and 243,808 respectively.

Figure 1. Spread rate of Worldwide infected cases
In the beginning, it increases slowly, when it is in the first phase of transmission, but once it reaches
into third/community transmission phase (community transmission phase is the one in which source
of infection cannot be traced) then the rate of increase in the number of cases is very high. For
example, the number of confirmed cases can be observed on April 2nd,2020, and April 12th, 2020
which is around 1.01M and 1.83M respectively showing a steep increase of 800K+ cases in small
tenure of 10 days. As per its widespread and worldwide impact, WHO declared COVID-19 as a
pandemic on March 11th, 2020.
At the time of writing (May 7th, 2020), the worldwide number of confirmed, recovered, and fatal
coronavirus cases are 3.7M+, 1.2M+, and 250K+ respectively and the mortality rate is more than
6.75%. If we look at the highly affected countries, leading the charts are United States of America
(from the North-American region), Spain, Italy, Germany (from European region), China, Iran (from
Eastern-Mediterranean region) and many other countries including India (from South-East Asia
region). As per the WHO report, around the whole world is suffering from this damning disease, and
its global risk assessment level is very high.
Unfortunately, until now, clinical features for identifying various stages of COVID-19 pneumonia
[5] is still not clear, due to that, infected persons are often being identified after reaching into severe
stages. Scientists are endeavoring to discover the drugs for their effective treatment. For the time

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

being, Chloroquine and Hydroxychloroquine have been found effective for controlling the
incisiveness of pneumonia, improving lung imaging findings, and promoting a virus-negative
conversion [6, 7]. Still, it is not a satisfactory solution because the rapid increase in the number of
cases can not be checked effectively and that leading to infect many others. Therefore, identifying
the cases in early-stage and quarantine the infected person is going to be a relevant solution.
There are many machine learning and deep transfer learning-based models being applied to X-Ray
images to detect COVID-19 cases effectively. But speedy and accurate detection is still a challenging
task. For this, we have proposed a deep transfer based learning model; which is an ensemble of
DenseNet121 and SqueezeNet1.0 to detect the COVID-19 cases effectively.
The remaining part of the paper is organized as follows. Section 2 highlights the related work which
covers a few recently published models in the area. Section 3 and 4 states the problem statement and
data acquisition, pre-processing respectively. Section 5 highlights the transfer learning, ensemble
learning, fundamental architecture of DenseNet121, and SqueezeNet. It also defines the proposed
model and its flow. The performance analysis of the proposed model is covered in section 6. Section
7 concludes the model and its importance.
2.

Related work

A few similar works have been done in which many deep learning techniques have been applied.
Applying these techniques over medical images such as X-Rays, CT Scans, MRI has been in practice
since long and success rate is quite significant [8, 9]. The implementations of deep learning
techniques have a wide range over multiple tasks such as disease diagnosis [10], survival rate
prediction [11], tumor segmentation [12], and many other applications. DenseNet is also being used
frequently in the field of medical imaging. Mentioning some noteworthy works, it is used for cardiac
segmentation and diagnosis [13], a fully connected framework is used for semantic segmentation
[14], a transfer learning-based framework is used on fundus medical images data [15], outcomes
have been quite encouraging in all these cases.
In the proposed model, we have used X-Ray images for prediction, which also have a wide range of
applications in deep learning, especially in case of pneumonia prediction, the symptoms of which are
very similar to that of COVID-19. A few highly accurate and clinically approved uses of X-Rays in
deep learning are, radiologist-level pneumonia detection, where architecture was constructed with
name ChexNet by Rajpurkar et. al [16] and tuberculosis detection using deep convolutional neural
network architecture called TX-CNN used in [17].
A few works have been done to diagnose the COVID-19 using machine learning and deep learning
frameworks, to note some, Narin et al. [18] propose to use a deep convolutional network-based
model called ResNet50 and compare its performance concerning two other models namely
InceptionV3 and InceptionResNetV2 for detecting coronavirus infected patients using X-Ray
images. Results establish that, among these three, ResNet50 is the best performing model in terms of
accuracy. But the reliability of this model is questionable, as it is tested on a quite small data set and
its performance needs to be observed on a larger dataset also.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Another noteworthy study has been performed by Sethy and Behra [18], where they have stacked a
support vector machine (SVM) in front of ResNet50 to detect corona virus-infected persons using Xray images.
A deep learning-based model to detect the disease from Chest CT scans using weak label [19] and an
Inception Net inspired model also using CT scans to predict the disease [20], were also some
recently published works on the same topic. Gaining motivation from all the aforementioned works,
the proposed model aims to achieve higher efficiency standards on a larger dataset so that it can be
used for clinical purposes.
3.

Problem Statement

Currently, many countries of the world, including India are suffering from COVID-19. A few
countries like the USA, Germany, Italy, and several others are facing its spread in the community
transfer phase, which indicates that one infected person can infect more than 100 people to whom he
contacts. So, the solution to the problem is to identify the infected persons and put them in
quarantine to stop the further spread. Existing diagnosis procedures to identify the infected person,
are time-consuming which is affecting the rate of diagnosis when dealing with a large number of
cases.
Therefore, for overcoming this issue, we have proposed a model, which can efficiently classify the
COVID-19 positive and negative cases well advance in time.
So, provided the problem, the task is to classify people as COVID-19 positive or COVID-19
negative, by using a suitable automated machine learning-based model. The model takes X-ray
images as an input parameter which are showing initial symptoms of the disease.
4.

Data

This section of the model states the data acquisition and discusses the pre-processing applied to the
data.
4.1 Background and Data Acquisition
The diagnosis of COVID-19 is confirmed by polymerase chain reaction (PCR), which is a complex
procedure comprising of heavy machinery and transfer requirement of test samples, consuming a lot
of time. Also, various studies suggest that patients suffering from pneumonia can be diagnosed by
observing the abnormalities in their respective chest X-rays or CT scans [21]. As we do in
pneumonia-like diseases, the same procedure can be followed with the patients showing symptoms
of COVID-19[22], which can save a lot of valuable time, as conducting X-rays is quite a feasible and
quick procedure, we can conduct a large number of tests in a short time.
So, for our study, we have used the chest X-Ray images of patients obtained from COVID-19 image
data collection [23], an open-source dataset. This dataset, at the time of the acquisition, was
significantly small and highly skewed towards COVID-19 positive samples. So, to increase our
sample size and make it skewed towards negative samples, transforming into a more realistic
scenario, we have included the X-Ray images of either normal or pneumonia infected people from
another open-source dataset [24] at Kaggle for the studies related to bacterial and viral pneumonia
prediction.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

4.2 Pre-Processing
The data collected from the aforementioned two sources is pre-processed to convert it into a usable
form, in which first, we have scaled all the images of data set to a uniform size of 512 Ã— 512 and
then distributed the data into three parts, training, validation and test sets. The data set contains 401
images out of which, 262 images are COVID-19 negative and the remaining 139 are for positive
cases. Firstly a set of 73 images was selected randomly for testing purposes. Out of these 73 selected
images, 21 were COVID-19 positive instances and the remaining 52 were COVID-19 negative
instances. The remaining images were randomly shuffled and then a 3:1 training-validation split was
performed, producing 246 images for training and 82 for validation purposes.
5.

The Model

The model section comprises an introduction to transfer learning, ensemble learning, DenseNet,
SqeezeNet and it also describes the definition and detailed architecture of the proposed model and in
the end, states the training pattern.
5.1 Transfer Learning
In modern machine-dependent automated prediction and classification tasks, deep learning is
considered to be the most sought-after concept, thanks to the remarkable performance obtained by it.
But it suffers from the problem of data-dependence, as, itâ€™s models require a tremendous amount of
data to train them, due to their complex architecture. The new find cases like COVID-19, have an
insufficient amount of training data, making it difficult to use deep learning architectures for tasks
related to them. Therefore, to deal with the problem of insufficient training data, an existing machine
learning tool has been used, which helps us to transfer pre-existing knowledge from other tasks or
the source domain to achieve the target for our concerning task or the target domain, this whole
procedure is known as transfer learning [25].
In case of deep learning, given a very deep neural network for one generalized task of image
classification, the initial layers and their weights are task-independent, only the final layers decide
which kind of image classification task it would be, so we can easily import the weights of the initial
layers of a pre-trained model and then train the final ones with whatever data we have, to make the
model task-specific. This whole process is broadly termed as deep transfer learning.
5.2 Ensemble Learning
Ensemble learning, in the context of deep neural networks, is training different neural networks with
the same input data configuration and measuring the average value of the predictions made by each
network to have our final prediction.
There are several methods to take the average, such as mean and mode. For our model, we have used
mean predictions.
Given ğ‘ neural networks, each making a prediction ğ‘ğ‘– , the final prediction P made by a mean-based
ensemble method is defined as mentioned in equation 1.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

ğ‘

ğ‘ƒ = 1/ğ‘ âˆ‘ ğ‘ğ‘–

(1)

ğ‘–=1

5.3 Model Selections to Ensemble
Using the same training, validation, and test data, we trained 5 deep transfer learning models namely
AlexNet, DenseNet121, ResNet50, VGG16, and SqueezeNet1.0. The best performing models out of
these 5 are DenseNet121 and SqueezeNet1.0. As indicated in figure 2, DenseNet121 and
SqueezeNet1.0 return the highest precision, recall, and accuracy values out of all five models.

Figure 2. Validation-set performance metrics for model selection
Also, an uncanny relation was there in between these 2 models on results got on test-set, that wrong
predictions made by the classifiers were mostly on different samples.
Hence, it is appropriate to take the ensemble of these two (DenseNet121 and SqueezeNet1.0)
models, to compensate for the errors of prediction of each other.
5.4 DenseNet
For image classification tasks, Convolutional Neural Networks (CNNs) are the state-of-the-art neural
architectures used all along with the world. With time, in an attempt to further improve the accuracy,
researchers have made many alterations with its architecture. As the complexities of tasks have
increased, therefore it is required to use deeper network architectures to process it effectively. Now,
as the hardware availability has improved significantly, true deep CNN architectures are being
proposed and trained. The barrier to the number of layers is being broken with time, be it 16 or 19
layers of VGG [26] or more than 100 layers in Highway Networks [27]. Also, a new trend is there to
pass the residues of a layer to layers way ahead of them as in ResNet [28], i.e. a layer-1 will not only
forward its feature map to layer-2 but can also forward it to layer-3, layer-4 or any forthcoming
layer. Multiple architectures have more than 1000 layers in them.
To further improve the information flow between layers, it is proposed to connect each layer to all its
subsequent layers i.e. for a given layer ğ‘™ the input ğ‘¥ğ‘™ is defined as in equation 1.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

ğ‘¥ğ‘™ = ğ»ğ‘™ [ğ‘¥0 , ğ‘¥1 , ğ‘¥2 , â€¦ . . , ğ‘¥ğ‘™âˆ’1 ]

(2)

Where, ğ»ğ‘™ [ğ‘¥0 , ğ‘¥1 , ğ‘¥2 , â€¦ . . , ğ‘¥ğ‘™âˆ’1 ] is a combined feature map of all previous layers [0,1,2, â€¦ . , ğ‘™ âˆ’ 1].
This process enabled very dense connectivity between layers and the resulting network is termed as
Dense Convolutional Network (DenseNet) [29].
Many DenseNet models are in use, here, DenseNet121 is used as one of the models for ensembling
into the proposed model, where 121 is the total number of layers present in the architecture. The task
flow in the DenseNet121 model can be visualized as shown in figure 3.
It is a deep DenseNet with four dense blocks, in which the layer between two adjacent blocks is
referred to as transition layers. The transition layers are intended to change the feature-map sizes via
convolution and pooling.
Input
Prediction

Dense Block 4
Linear

Pooling

Pooling

Convolution

Dense Block 3
Pooling

Convolution

Dense Block 2
Pooling

Convolution

Convolution

Dense Block 1

COVID-19

Figure 3. An Architecture of the DenseNet121 model
The architecture takes the image as input and after detection shows the output in the form of
COVID-19 positive or negative.
5.5 SqueezeNet
This model also was a breakthrough in the field of true deep convolutional neural networks. The
main goal achieved by this model was to gain AlexNet level accuracy while minimizing the number
of parameters as compared to AlexNet to a great extent.
The model, in an uncompressed form, is consists of 50x fewer parameters than AlexNet, and do also
maintains the same accuracy level as AlexNet, over ImageNet data.
In order to achieve the aforementioned goals, this model introduced a novel concept of fire module.
The model uses 9 fire modules in total, each having two blocks, squeeze block, having 3 1x1
convolution filters, and an expand block having 3 1x1 as well as 4 3x3 convolution filters [30].
The first version of this model, named SqueezeNet1.0 has been used in this study.
5.6 The Proposed Model
The proposed model is an ensemble of DenseNet121 and SqueezNet1.0, in an attempt to increase the
efficiency of Covid-19 prediction.
For this model, we separately train DenseNet121 and SqueezeNet1.0, and then on any given chest Xray images from the data sample, take the mean of the prediction probabilities obtained from these
two DenseNet121 and SqueezeNet models to get the final prediction. For any given chest X-Ray
image I, the function of DenseNet121 and SqueezeNet1.0 can be expressed as follows.
ğ‘‘
ğ‘‘
âŒª
ğ‘“ğ·ğ‘’ğ‘›ğ‘ ğ‘’ğ‘ğ‘’ğ‘¡121 (ğ¼) = âŒ©ğ‘ğ‘ğ‘œğ‘£ğ‘–ğ‘‘
, ğ‘ğ‘œğ‘¡â„ğ‘’ğ‘Ÿ

(3)

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

And,
ğ‘ 
ğ‘ 
âŒª
ğ‘“ğ‘†ğ‘ğ‘¢ğ‘’ğ‘’ğ‘§ğ‘’ğ‘ğ‘’ğ‘¡1.0 (ğ¼) = âŒ©ğ‘ğ‘ğ‘œğ‘£ğ‘–ğ‘‘
, ğ‘ğ‘œğ‘¡â„ğ‘’ğ‘Ÿ

(4)

ğ‘‘
Equation 3 is the function for DenseNet121, with output ğ‘ğ‘ğ‘œğ‘£ğ‘–ğ‘‘
as the probability of ğ¼ being a
ğ‘‘
COVID-19 positive sample and ğ‘ğ‘œğ‘¡â„ğ‘’ğ‘Ÿ as the probability of ğ¼ being a COVID-19 negative sample.
ğ‘ 
And equation 4 is the function of SqueezeNet1.0, with output ğ‘ğ‘ğ‘œğ‘£ğ‘–ğ‘‘
as the probability of ğ¼ being a
ğ‘ 
COVID-19 positive sample and ğ‘ğ‘œğ‘¡â„ğ‘’ğ‘Ÿ as the probability of ğ¼ being a COVID-19 negative sample.

Now, for the proposed model i.e. DeQueezeNet, the probability of X-ray image ğ¼ being COVID-19
positive is shown by equation 5.
ğ‘‘ğ‘
ğ‘ğ‘ğ‘œğ‘£ğ‘–ğ‘‘
=

ğ‘‘
ğ‘ 
(ğ‘ğ‘ğ‘œğ‘£ğ‘–ğ‘‘
+ ğ‘ğ‘ğ‘œğ‘£ğ‘–ğ‘‘
)
2

(5)

Where equation 6 indicates the probability of image I being COVID-19 negative.
ğ‘‘ğ‘
ğ‘ğ‘œğ‘¡â„ğ‘’ğ‘Ÿ

ğ‘‘
ğ‘ 
(ğ‘ğ‘œğ‘¡â„ğ‘’ğ‘Ÿ
+ ğ‘ğ‘œğ‘¡â„ğ‘’ğ‘Ÿ
)
=
2

(6)

Hence the final predicted class of image ğ¼ by DeQueezeNet (The proposed model), denoted by Ïƒ,
returning either 0 (denoting COVID-19 positive class) or 1 (denoting COVID-19 negative class), can
be written as mentioned in equation 7.
ğ‘‘ğ‘
ğ‘‘ğ‘
âŒª
ğœğ·ğ‘’ğ‘ğ‘¢ğ‘’ğ‘’ğ‘§ğ‘’ğ‘ğ‘’ğ‘¡ (ğ¼) = ğ‘ğ‘Ÿğ‘”ğ‘šğ‘ğ‘¥âŒ©ğ‘ğ‘ğ‘œğ‘£ğ‘–ğ‘‘
, ğ‘ğ‘œğ‘¡â„ğ‘’ğ‘Ÿ

(7)

5.7 Flow chart of DeQueezeNet
Figure 4 shows the flow chart of the proposed model i.e. DeQueezeNet, which is an ensemble
version of Squuezenet1.0 and DenseNet121.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Input Data Set

Pre-Processing

Image Rescaling

Data Splitting
Test Set

Training Set

Validation Set

Find Learning
Rate

Find Learning
Rate

Train for 30
epochs

Train for 30
epochs

Validate

Validate

Fully Trained
DenseNet121

Fully Trained
SqueezeNet1_0

Prediction

Prediction

Prediction
Probability of
DenseNet121

Prediction
Probability of
SqueezeNet1_0

Ensemble

Final Prediction

Figure 4. Flowchart of the proposed model
As shown in figure 4, we take the X-ray image dataset as input and resize all images as a part of preprocessing into 512 Ã— 512 and reserve a fraction of the dataset [73 images] for testing purposes.
The rest part of the pre-processed data set is split into training and validation set, in which 75% of
the data is for the training and the remaining 25% for the validation set.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Using the training dataset, we train DenseNet121 and SqueezeNet1.0 separately, followed by
validation of the trained models.
Fully trained and validated models take the test set as input and predict the outcome in terms of
probability. And these predicted probabilities are ensembled for further processing.
In the final step, the probability obtained after the ensemble is used to predict the COVID-19 positive
and negative cases.
5.7 Model Training
The models used for the ensemble in the proposed are trained as follows.
Although there are multiple variants of DenseNet and SqueezeNet we have utilized DenseNet121
(121 is the number of layers present) and SqueezeNet1.0 (the first version of SqueezeNet) for our
study.
Due to limited availability of data, transfer learning method has been used, so we imported a pretrained model of DenseNet121 over, ImageNet, which is an image database consisting of millions of
images organized according to the WordNet hierarchy where each node of the hierarchy is
represented by a collection of images, averaging 500 images per node [31]. The model was imported
from fastai library [32] and then our training and validation data were fed onto it.
For training both the models (DenseNet121 and SqueezeNet1.0), we have used the LR-finder module
of fastai [30] to find the optimal learning rate suited for the training data. The LR-finder works by
selecting a sequence of learning rates and training the models for 1 epoch each, using each learning
rate. In the case of the high learning rate, loss of information starts to explode or increases
exponentially. Therefore, admissible maximum learning rates are chosen for training the models.

Figure 5. The outcome of LR-finder module on DenseNet121

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Figure 6. The outcome of LR-finder module on SqueezeNet 1.0
In figure 5 and figure 6, the learning rate versus loss plot after running the LR-finder module is
shown, with figure 5 denoting plot for DenseNet121 and figure 6 denoting plot for SqueezeNet1.0.
From the observation, it is derived that the maximum permissible learning rate for the model
DenseNet121 is 1ğ‘’â€“ 04 and for SqueezeNet1.0 is 2ğ‘’â€“04 because, beyond these levels, the loss starts
to increase exponentially. Both the models are trained for 30 epochs, using there aforementioned
maximum learning rates utilizing fit-one-cycle policy [31]. In fit-one-cycle policy, the learning rate
is adjusted slightly after completion of each epoch.
6.

Performance Analysis and Comparative Study

For studying the performance of the proposed model, programming is done on Python-3 and the
model is trained and tested on Google Colaboratory, a cloud-based programming platform.
Performance analysis of the proposed model is observed by plotting the confusion matrix for
validation and test samples and the comparative study indicates the importance of the model.
6.1

Performance Metrics

A few important metrics used to compare the performance of the proposed model to other models are
as follows.
6.1.1

Losses on training and validation

The loss is basically calculated by computing the difference between the actual and predicted values
of the class probabilities. While comparing the models based on their losses, we have to look for
three factors; first, the loss should be low and its difference should be as low as possible, second, if
the training loss is much lesser than the validation loss, then the corresponding model is overfitting,
and the third, if the validation loss is lesser than training loss, then the corresponding model is
underfitting. The loss function used in our model is Softmax, quite a popular function for calculating
the loss in binary classification.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

6.1.2

Accuracy

Accuracy [33] is calculated as the percentage of samples correctly classified concerning the total
number of samples as indicated in equation 8. In which, ğ‘† is the total sample size, ğ‘¦Ì‚ğ‘  denotes the
predicted label and ğ‘¦ğ‘  denotes the ground truth label.
1

ğ´ğ‘ğ‘ğ‘¢ğ‘Ÿğ‘ğ‘ğ‘¦ = ğ‘† âˆ‘ğ‘†ğ‘ =1[ğ‘¦Ì‚ğ‘  = ğ‘¦ğ‘  ] ğ‘‚ğ‘…

ğ‘‡ğ‘ƒ+ğ‘‡ğ‘
ğ‘‡ğ‘ƒ+ğ‘‡ğ‘+ğ¹ğ‘ƒ+ğ¹ğ‘

(8)

Where TP: true positive, TN: true negative, FP: false positive and FN is a false negative.
A higher accuracy value approves the effectiveness of the model.
6.1.3

Precision

In machine learning, precision [33] shown in equation 9, is defined as the percentage of a specific
class of samples correctly guessed by a model to the total number of samples of that very class. In
the proposed model, the class is of COVID-19 positive people, which is considered for it.
ğ‘ƒğ‘Ÿğ‘’ğ‘ğ‘–ğ‘ ğ‘–ğ‘œğ‘› =

ğ‘‡ğ‘ƒ

(9)

ğ‘‡ğ‘ƒ+ğ¹ğ‘ƒ

6.1.4

Recall

Recall is defined as the percentage of actual positive samples predicted correctly. In the proposed
model, it is calculated in the form of a percentage of COVID-19 positive samples correct predictions.
It can be calculated with the help of equation 10.
ğ‘‡ğ‘ƒ

ğ‘…ğ‘’ğ‘ğ‘ğ‘™ğ‘™ = ğ‘‡ğ‘ƒ+ğ¹ğ‘
6.1.5

(10)
Area under ROC curve (AUROC)

Receiver Operating Characteristics (ROC) curve [33] is a graphical representation of the true
positive rate (TPR) plotted against the false positive rate (FPR). TPR and FPR can be calculated as
given in equations 11 and 12. The higher TPR and lower FPR incur the high percentage area inside
the plot, indicates, how much better a model is interpreted to be.
ğ‘‡ğ‘ƒ

ğ‘‡ğ‘ƒğ‘… = ğ‘‡ğ‘ƒ+ğ¹ğ‘
ğ¹ğ‘ƒ

ğ¹ğ‘ƒğ‘… = ğ‘‡ğ‘+ğ¹ğ‘ƒ
6.2

(11)
(12)

Confusion Matrix

The confusion matrix is shown to analyze the performance of the proposed model DequeezeNet. On
the test set, Figure 7 shows the outcomes obtained by the DeQueezeNet model.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Figure 7 Confusion Matrix of proposed Model DeQueezeNet
Observation from the figure 7 shows that out of 21 positive samples, 19 were classified correctly,
and out of 52 negative samples, 50 were classified correctly, making it 69 out of 73 correct
predictions, with an accuracy of 94.52 %, precision of 90.48% and recall of 96.15%. All of which are
pretty decent scores, emphasizing the usability of the model in practical and clinical cases.
6.3

Comparative Analysis

To study the comparative performance of the proposed model, we chose 3 different models for
comparison, DenseNet121, SqueezeNet1.0 (both models have been used to build the proposed model
DeQueezeNet), and ResNet50 is given by Narin et al. [34] for detecting the coronavirus disease
using X-ray images.

Figure 8. Comparative Accuracy over the number of epochs
These models are applied to predict the COVID-19 positive and negative cases, figure 8 shows the
accuracy over the varying number of epochs from 1 to 30.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Observation from figure 8 shows that the proposed model DeQueezeNet is performing
better than all the other models for every epoch of training. The proposed modelâ€™s
performance is better even when it is trained for just one epoch.
The second set of comparative study is done to observe the Percentage Score of the
proposed model. All the models are trained up to 30 epochs before applying over the
Test-Set data sample. Figure 9 shows that the percentage score is shown in terms of
Accuracy, Precision, and Recall.

Figure 9. Comparative performance in terms of percentage score
Observation from figure 9, shows that the proposed model DeQueezeNet is performing better than
all the other three models in terms of accuracy, precision, and recall. The performance of the
DeQueezeNet is not only better than SqueezeNet1.0 and DenseNet121 but it is also better than
recently proposed model ResNet50 [34] by Narin et al.
7.

Conclusion

In this paper, we have proposed an ensemble-based DeQueezeNet model which consists of
DenseNet121 and SqueezeNet1.0. The performance evaluation is done by applying the model on Xray images to predict COVID-19 positive and negative cases.
Performance evaluation is done by considering the performance metrics which are accuracy,
precision, and Recall. The confusion matrix shows that the proposed model can identify the COVID19 positive and negative cases effectively. Suitable accuracy and high precision imply the
significance of the model.
A comparative study is also done with recent work on the above-stated performance metrics. In
which, it is observed that performance of the proposed model significantly better which signifies the
importance of the model. And it also justifies that the proposed model is best suited for classifying
the COVID-19 positive and negative cases.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

References
[1]
[2]

[3]
[4]
[5]

[6]
[7]

[8]
[9]
[10]

[11]

[12]
[13]

[14]
[15]
[16]

[17]
[18]
[19]
[20]

J. Guarner, "Three emerging coronaviruses in two decades: the story of SARS, MERS, and now
COVID-19," Oxford University Press US, 2020.
S. Kharitonov, D. Yates, and P. Barnes, â€œIncreased nitric oxide in exhaled air of normal human
subjects with upper respiratory tract infections,â€ European Respiratory Journal, vol. 8, no. 2, pp. 295297, 1995.
J. A. Al-Tawfiq, A. Assiri, and Z. A. Memish, â€œMiddle East respiratory syndrome novel corona (MERSCoV) infection,â€ Saudi Med J, vol. 34, no. 10, pp. 991-994, 2013.
S. Khan, R. Siddique, A. Ali, M. Xue, and G. Nabi, â€œNovel coronavirus, poor quarantine, and the risk of
pandemic,â€ Journal of Hospital Infection, 2020.
L. Yan, H.-T. Zhang, Y. Xiao, M. Wang, C. Sun, J. Liang, S. Li, M. Zhang, Y. Guo, and Y. Xiao, â€œPrediction
of survival for severe Covid-19 patients with three clinical features: development of a machine
learning-based prognostic model with clinical data in Wuhan,â€ medRxiv, 2020.
J. Gao, Z. Tian, and X. Yang, â€œBreakthrough: Chloroquine phosphate has shown apparent efficacy in
treatment of COVID-19 associated pneumonia in clinical studies,â€ Bioscience trends, 2020.
P. GAUTRET, J. C. LAGIER, P. PAROLA, L. MEDDED, M. MAILHE, B. DOUDIER, J. COURJON, V.
GIORDANENGO, V. E. VIEIRA, and H. T. DUPONT, â€œHydroxychloroquine and Azithromycin as a
treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial,â€ medRxiv,
2020.
A. S. Lundervold, and A. Lundervold, â€œAn overview of deep learning in medical imaging focusing on
MRI,â€ Zeitschrift fÃ¼r Medizinische Physik, vol. 29, no. 2, pp. 102-127, 2019.
M. I. Razzak, S. Naz, and A. Zaib, "Deep learning for medical image processing: Overview, challenges
and the future," Classification in BioApps, pp. 323-350: Springer, 2018.
V. Gulshan, L. Peng, M. Coram, M. C. Stumpe, D. Wu, A. Narayanaswamy, S. Venugopalan, K. Widner,
T. Madams, and J. Cuadros, â€œDevelopment and validation of a deep learning algorithm for detection
of diabetic retinopathy in retinal fundus photographs,â€ Jama, vol. 316, no. 22, pp. 2402-2410, 2016.
W. Han, L. Qin, C. Bay, X. Chen, K.-H. Yu, N. Miskin, A. Li, X. Xu, and G. Young, â€œDeep Transfer
Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas,â€
American Journal of Neuroradiology, vol. 41, no. 1, pp. 40-48, 2020.
Z. Cui, J. Yang, and Y. Qiao, "Brain MRI segmentation with patch-based CNN approach." pp. 70267031.
M. Khened, V. A. Kollerathu, and G. Krishnamurthi, â€œFully convolutional multi-scale residual
DenseNets for cardiac segmentation and automated cardiac diagnosis using ensemble of classifiers,â€
Medical image analysis, vol. 51, pp. 21-45, 2019.
S. JÃ©gou, M. Drozdzal, D. Vazquez, A. Romero, and Y. Bengio, "The one hundred layers tiramisu: Fully
convolutional densenets for semantic segmentation." pp. 11-19.
X. Xu, J. Lin, Y. Tao, and X. Wang, "An Improved DenseNet Method Based on Transfer Learning for
Fundus Medical Images." pp. 137-140.
P. Rajpurkar, J. Irvin, K. Zhu, B. Yang, H. Mehta, T. Duan, D. Ding, A. Bagul, C. Langlotz, and K.
Shpanskaya, â€œChexnet: Radiologist-level pneumonia detection on chest x-rays with deep learning,â€
arXiv preprint arXiv:1711.05225, 2017.
C. Liu, Y. Cao, M. Alcantara, B. Liu, M. Brunette, J. Peinado, and W. Curioso, "TX-CNN: Detecting
tuberculosis in chest X-ray images using convolutional neural network." pp. 2314-2318.
P. K. Sethy, and S. K. Behera, â€œDetection of coronavirus disease (covid-19) based on deep features,â€
Preprints, vol. 2020030300, pp. 2020, 2020.
C. Zheng, X. Deng, Q. Fu, Q. Zhou, J. Feng, H. Ma, W. Liu, and X. Wang, â€œDeep Learning-based
Detection for COVID-19 from Chest CT using Weak Label,â€ medRxiv, 2020.
S. Wang, B. Kang, J. Ma, X. Zeng, M. Xiao, J. Guo, M. Cai, J. Yang, Y. Li, and X. Meng, â€œA deep learning
algorithm using CT images to screen for Corona Virus Disease (COVID-19),â€ medRxiv, 2020.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.12.20099937; this version posted May 14, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

[21]

[22]

[23]
[24]

[25]
[26]

[27]
[28]
[29]
[30]

[31]
[32]
[33]
[34]

D. S. Kermany, M. Goldbaum, W. Cai, C. C. Valentim, H. Liang, S. L. Baxter, A. McKeown, G. Yang, X.
Wu, and F. Yan, â€œIdentifying medical diagnoses and treatable diseases by image-based deep
learning,â€ Cell, vol. 172, no. 5, pp. 1122-1131. e9, 2018.
M.-Y. Ng, E. Y. Lee, J. Yang, F. Yang, X. Li, H. Wang, M. M.-s. Lui, C. S.-Y. Lo, B. Leung, and P.-L. Khong,
â€œImaging profile of the COVID-19 infection: radiologic findings and literature review,â€ Radiology:
Cardiothoracic Imaging, vol. 2, no. 1, pp. e200034, 2020.
J. P. Cohen, P. Morrison, and L. Dao, â€œCovid-19 image data collection,â€ arXiv preprint
arXiv:2003.11597, 2020.
D. Kermany, K. Zhang, and M. Goldbaum, â€œLarge Dataset of Labeled Optical Coherence Tomography
(OCT) and Chest X-Ray Images,â€ Mendeley Data, v3 http://dx. doi. org/10.17632/rscbjbr9sj, vol. 3,
2018.
C. Tan, F. Sun, T. Kong, W. Zhang, C. Yang, and C. Liu, "A survey on deep transfer learning." pp. 270279.
O. Russakovsky, J. Deng, H. Su, J. Krause, S. Satheesh, S. Ma, Z. Huang, A. Karpathy, A. Khosla, and M.
Bernstein, â€œImagenet large scale visual recognition challenge,â€ International journal of computer
vision, vol. 115, no. 3, pp. 211-252, 2015.
R. K. Srivastava, K. Greff, and J. Schmidhuber, "Training very deep networks." pp. 2377-2385.
K. He, X. Zhang, S. Ren, and J. Sun, "Deep residual learning for image recognition." pp. 770-778.
G. Huang, Z. Liu, L. Van Der Maaten, and K. Q. Weinberger, "Densely connected convolutional
networks." pp. 4700-4708.
F. N. Iandola, S. Han, M. W. Moskewicz, K. Ashraf, W. J. Dally, and K. Keutzer, â€œSqueezeNet: AlexNetlevel accuracy with 50x fewer parameters and< 0.5 MB model size,â€ arXiv preprint arXiv:1602.07360,
2016.
J. Deng, W. Dong, R. Socher, L.-J. Li, K. Li, and L. Fei-Fei, "Imagenet: A large-scale hierarchical image
database." pp. 248-255.
J. Howard, and S. Gugger, â€œfastai: A Layered API for Deep Learning,â€ Information, vol. 11, no. 2, pp.
108, 2020.
D. Powers, â€œEvaluation: from precision, recall and f-factor to roc, informedness, markedness
andamp; correlation,â€ J Mach Learn Technol, vol. 2, pp. 2229-3981, 2008.
A. Narin, C. Kaya, and Z. Pamuk, â€œAutomatic detection of coronavirus disease (covid-19) using x-ray
images and deep convolutional neural networks,â€ arXiv preprint arXiv:2003.10849, 2020.

